Showing results (2931-2940 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|August 27, 2013
Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosisRavi K Prakash, Sowjanya Kanna, Kevin D Mullen
Clinical Therapeutics|August 27, 2013
Effects of dividing amlodipine daily doses on trough drug concentrations and blood pressure control over a 24-hour periodKen-ichi Miyoshi, Takafumi Okura, Tomoaki Nagao, et al.
Clinical Therapeutics|August 27, 2013
Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trialSonya N Burgess, Christian J Mussap, John K French
Clinical Therapeutics|August 27, 2013
Improving outcomes after acute coronary syndrome with rehabilitation and secondary preventionTom Briffa, Clara K Chow, Alexander M Clark, et al.
Clinical Therapeutics|September 24, 2013
Discovery of novel drugs for promising targetsRobert E Martell, David G Brooks, Yan Wang, et al.
Clinical Therapeutics|September 24, 2013
Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation studyHeino Stass, Boris Weimann, Johannes Nagelschmitz, et al.
Clinical Therapeutics|September 3, 2013
Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertensionKathleen A Matthews, Michael J Brenner, Allison C Brenner
Clinical Therapeutics|September 4, 2013
A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial)Kevin C Maki, David G Orloff, Stephen J Nicholls, et al.
Clinical Therapeutics|January 1, 1990
Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis groupH M Wexler, S M Finegold
Clinical Therapeutics|June 25, 2013
Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratingsRonnie Aronson, Michael A Gibney, Kunjal Oza, et al.
Pageof 680